Skip to content

Product2 publishers3 min readPublished

Grindr to acquire Freddie's parent in $250 million deal to help users start and stay on PrEP

Grindr agreed to buy PrEP provider Freddie for $250 million in cash and stock, its first major acquisition, to offer HIV prevention care inside its app. Whether it pays off depends on how many users keep refilling a daily pill through the app once they start.

The Product Desk · Product desk

Illustration accompanying Grindr to acquire Freddie's parent in $250 million deal to help users start and stay on PrEP

What happened

  • Grindr will pay $190 million in cash and $60 million in shares, with up to $70 million more in cash if Freddie hits targets in 2027, and expects to close by the end of the year.
  • Freddie, founded in Canada in 2020, has helped more than 55,000 patients in Canada and the US get PrEP and now serves patients in all 50 states.
  • Grindr plans to fold Freddie and Woodwork, the erectile dysfunction service it launched in 2025, into a single Grindr Health offer.
  • UK users sued Grindr in 2024 claiming it shared their HIV status with advertisers, and Grindr has denied ever selling health data.

Compiled by The Product DeskSomething wrong?How this is made

Why it matters

  • capability Grindr can run prescribing, testing and pharmacy delivery under its own brand, using Freddie's clinicians and regulated-healthcare operations, with Freddie's leaders staying on to run them.
  • exposure Prescription and testing records for an HIV-prevention service will sit inside a company UK users have sued over HIV-status sharing, so any future privacy failure would involve clinical data.
  • cost By Grindr's own warning, shareholders absorb thinner margins during the build-out before any growth in Freddie's patient base can show up in results.

Once the deal closes, a Grindr user will be able to read about PrEP, review coverage and begin an assessment without leaving the app they use for dating [4]. The release then lays out a clinician visit, testing and a prescription, followed by home delivery, refill management and reminders, which is the only stage that repeats [4].

George Arison, Grindr's chief executive, described the problem the same way. "The challenge is connecting people to PrEP and helping them stay on it," he said [5]. The release says eligible US patients can get the daily pill at little to no out-of-pocket cost, and that it cuts HIV risk by about 99% [15][16]. By the release's count, about 650,000 people in the US take it, against an estimated 2.2 million who could benefit [8]. That leaves roughly 1.55 million people uncovered, so about 30% of the eligible population is on the drug [1][2].

The release states its theory of retention in one sentence: "Keeping testing, refills, and support in a familiar place helps patients stay engaged with the recurring care that makes prevention effective" [6]. This is what product teams tell themselves users do. Someone who opens a dating app often has not thereby shown they will act on a refill reminder inside it. What users actually do would show up in a persistence rate, and the companies did not publish one for Freddie's 55,000-plus patients [7].

The reach is real. Grindr says it has nearly 16 million monthly users [9]. Freddie's total patient count since 2020 is about a third of one percent of that monthly figure [6].

Grindr is paying $250 million up front, and up to $320 million if the full earnout is paid [3]. Freddie expects more than $80 million in revenue this year, according to The Next Web, which puts the up-front price at no more than about 3.1 times sales, or 4 times with the full earnout [4]. Against more than $10 million in adjusted earnings, the price is no more than 25 times [5].

The release promises that Grindr users can decline Freddie and that Freddie's patients can decline Grindr [12]. I think the second promise exists because some patients will not want one company holding both their HIV-prevention care and their dating profile.

A team weighing a similar bolt-on can use a 2x2. One axis is whether the host app reaches people the service misses today. The other is whether users are comfortable with the host knowing they use the service. High reach with high comfort argues for full embedding. High reach with low comfort argues for a separate login and separate records behind a link. Low reach turns the deal into an expensive referral channel at any comfort level. Grindr and Freddie score high on reach and split on comfort [1][12].

For Grindr, I would build the embedded version and keep Freddie's accounts and records separate from the dating profile. Then I would judge the deal on one number: the share of patients referred through Grindr who are still refilling after twelve months, compared with Freddie's direct patients [4][7]. The tradeoff is that separate accounts and records give up some of the one-app convenience the release is selling [6].

What to watch

  • Whether Grindr or Freddie publishes refill or twelve-month persistence rates for patients who arrive through the app.
  • The 2027 performance targets behind the $70 million earnout, and whether Freddie meets them.
  • How Grindr separates Freddie's clinical records from its dating and advertising systems after the deal closes in the fourth quarter.
Loading claim ledger
Loading source directory links
Loading share composer
Loading topic controls
Loading related stories